HIGHLIGHTS
- who: Erik Ehinger from the Neurosurgery, Department of Clinical, University, Sku00e5ne have published the research: Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma, in the Journal: (JOURNAL)
- what: In this pilot study the authors evaluate the safety and feasibility of add-on Salovum in GBM patients. The authors show that add-on treatment with the AF-enriched dietary supplement Salovum is safe and feasible for patients with GBM undergoing concomitant radiochemotherapy. The study was designed to evaluate safety and feasibility and as such presents with limitations when assessing secondary . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.